Insider filing · IQV
John G Danhakl
Director
profile →
IQVIA Holdings Inc.
IQV · Healthcare · 19 filings in 24 months
ticker →
John G Danhakl bought $256K of IQVIA (IQV)
Executed Dec 3 2024, disclosed Feb 7 2025, 66 days later, against a two-business-day limit.
Value, as filed
$256K
1,275 sh × $200.58
Executed
Dec 3 2024
the trade date, as filed
Disclosed
Feb 7 2025
66 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
-10.8%
-3.1% from execution
Over the 21 trading sessions from the disclosed entry session (Feb 7 2025), the stock returned -10.8% (delay-adjusted); from the execution session (Dec 3 2024), -3.1%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
JDJohn G Danhakl (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Life Time Group Holdings, Inc. (LTH). The largest single filing was $220.9M of LTH (5,119,099 sh × $43.16, as filed), executed Aug 10.
The name
IQVHealthcare · IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthca…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→